Cargando…

Role of Histone Deacetylases in the Pathogenesis of Salivary Gland Tumors and Therapeutic Targeting Options

Salivary gland tumors (SGTs) comprise a rare and heterogenous category of benign/malignant neoplasms with progressively increasing knowledge of the molecular mechanisms underpinning their pathogenesis, poor prognosis, and therapeutic treatment efficacy. Emerging data are pointing toward an interplay...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manou, Maria, Kanakoglou, Dimitrios S., Loupis, Theodoros, Vrachnos, Dimitrios M., Theocharis, Stamatios, Papavassiliou, Athanasios G., Piperi, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298439/ https://www.ncbi.nlm.nih.gov/pubmed/37373187 http://dx.doi.org/10.3390/ijms241210038

Ejemplares similares

Enhanced Transcriptional Signature and Expression of Histone-Modifying Enzymes in Salivary Gland Tumors
por: Manou, Maria, et al.
Publicado: (2023)

Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors
por: Pouloudi, Despoina, et al.
Publicado: (2021)

Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia
por: Goutas, Dimitrios, et al.
Publicado: (2021)

Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis
por: Markouli, Mariam, et al.
Publicado: (2022)

Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis
por: Markouli, Mariam, et al.
Publicado: (2021)

Transcription Factors with Targeting Potential in Gliomas
por: Giannopoulou, Angeliki-Ioanna, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma
por: Psilopatis, Iason, et al.
Publicado: (2021)

Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies
por: Markouli, Mariam, et al.
Publicado: (2022)

Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity
por: Markouli, Mariam, et al.
Publicado: (2021)

Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer
por: Kanakoglou, Dimitrios S., et al.
Publicado: (2022)

Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma
por: Palamaris, Kostas, et al.
Publicado: (2022)

Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors
por: Palamaris, Kostas, et al.
Publicado: (2023)

Dissecting the Role of Circular RNAs in Sarcomas with Emphasis on Osteosarcomas
por: Lakiotaki, Eleftheria, et al.
Publicado: (2021)

Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
por: Ke, Xiangyu, et al.
Publicado: (2021)

Polycystin‐1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro
por: Zoi, Ilianna, et al.
Publicado: (2022)

Exploring the Multi-Faceted Role of Sirtuins in Glioblastoma Pathogenesis and Targeting Options
por: Kunadis, Elena, et al.
Publicado: (2022)

Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
por: Piperi, Christina, et al.
Publicado: (2019)

The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors
por: Pouloudi, Despoina, et al.
Publicado: (2020)

The Controversial Role of Autophagy in Ewing Sarcoma Pathogenesis—Current Treatment Options
por: Koustas, Evangelos, et al.
Publicado: (2021)

Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
por: Korfei, Martina, et al.
Publicado: (2022)

Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas
por: MANTA, ASPASIA, et al.
Publicado: (2023)

Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
por: Schizas, Dimitrios, et al.
Publicado: (2018)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Polycystin‐1 modulates RUNX2 activation and osteocalcin gene expression via ERK signalling in a human craniosynostosis cell model
por: Katsianou, Maira, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
por: Garmpis, Nikolaos, et al.
Publicado: (2021)

Aplasia of the Major and Minor Salivary Glands: Report of a Rare Case
por: Papadopoulou, Erofili, et al.
Publicado: (2022)

Outline of Salivary Gland Pathogenesis of Sjögren’s Syndrome and Current Therapeutic Approaches
por: Yura, Yoshiaki, et al.
Publicado: (2023)

Interaction of Human Salivary Gland Epithelial Cells with B Lymphocytes: Implications in the Pathogenesis of Sjögren’s Syndrome
por: Kapsogeorgou, Efstathia K., et al.
Publicado: (2020)

The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury
por: Ning, Li, et al.
Publicado: (2021)

Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients’ Survival
por: Levidou, Georgia, et al.
Publicado: (2021)

Role of histone deacetylase inhibitors in diabetic cardiomyopathy in experimental models (Review)
por: Garmpi, Anna, et al.
Publicado: (2022)

Polycystin‐1 regulates cell proliferation and migration through AKT/mTORC2 pathway in a human craniosynostosis cell model
por: Katsianou, Maria A., et al.
Publicado: (2022)

Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance
por: Goutas, Dimitrios, et al.
Publicado: (2021)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules
por: Vallilas, Christos, et al.
Publicado: (2021)

The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities
por: Psilopatis, Iason, et al.
Publicado: (2023)

Histone Deacetylase 9: Its Role in the Pathogenesis of Diabetes and Other Chronic Diseases
por: Hu, Siqi, et al.
Publicado: (2020)

Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
por: Schmidt, Oxana, et al.
Publicado: (2021)

The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023)

Histone deacetylase (HDAC)-1, −2, −4 and −6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survival
por: Giaginis, Constantinos, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6f54eoe22erm1g0jgtgkhsuocu